Shopping Cart
- Remove All
Your shopping cart is currently empty
Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medications.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | Inquiry | 1-2 weeks | |
| 50 mg | Inquiry | 1-2 weeks | |
| 100 mg | Inquiry | 1-2 weeks |
| Description | Grazoprevir, a second generation hepatitis C virus protease inhibitor acting at the NS3/4a protease targets, has good activity against a range of hepatitis C virus genotype variants, including some that are resistant to most currently used antiviral medications. |
| Targets&IC50 | GT1a:0.01±0.01 nM (Ki), GT1b:0.01±<0.01 nM (Ki), GT2a:0.08±0.02 nM (Ki), GT2b:0.15±0.06 nM (Ki), GT3a:0.90±0.2 nM (Ki) |
| Synonyms | MK-5172, MK5172, MK 5172, Grazoprevir |
| Molecular Weight | 784.92 |
| Formula | C38H52N6O10S |
| Cas No. | 1350462-55-3 |
| Relative Density. | no data available |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | DMSO: Soluble H2O: Insoluble |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.